Patents by Inventor Yumi UNNO

Yumi UNNO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220146526
    Abstract: A method for evaluating a sample includes obtaining a blood plasma sample prepared from human blood, conducting detection of a predetermined molecule in the blood plasma sample, and evaluating the quality of the blood plasma sample based on the intensity of the molecule acquired by the detection.
    Type: Application
    Filed: January 27, 2020
    Publication date: May 12, 2022
    Applicant: SHIMADZU CORPORATION
    Inventors: Yumi UNNO, Shuichi KAWANA, Yutaka AOKI, Junichi MASUDA, Hirotaka FUJIMOTO, Tsuyoshi NAKANISHI
  • Patent number: 10928363
    Abstract: At least one stable isotope reagent is added to each biological sample and standard sample to prepare biological samples for analysis and standard sample for analysis. The quality of the biological samples is evaluated using data of one set of biological samples for analysis composed of a plurality of biological samples for analysis. Besides, the quality of a pretreatment and/or analysis of each set of samples for analysis is evaluated using data obtained by analyzing the standard sample for analysis before and after an analysis of one set of samples for analysis. An abnormality in a chromatograph or mass analyzer used for the analysis of one set of samples is evaluated by the data obtained by analyzing a sample for device evaluation before and after the analysis of one set of samples for analysis. Thus, the quality of data obtained by chromatographic mass spectrometry on biological samples is comprehensively evaluated.
    Type: Grant
    Filed: February 1, 2018
    Date of Patent: February 23, 2021
    Assignees: SHIMADZU CORPORATION, NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY
    Inventors: Noriyuki Ojima, Shuichi Kawana, Yumi Unno, Takero Sakai, Kenichi Obayashi, Yukihiko Kudo, Katsuyuki Taneda, Masaru Yoshida, Shin Nishiumi, Takashi Kobayashi, Takeshi Azuma
  • Publication number: 20180299448
    Abstract: Provided is a colorectal cancer inspection method by which the presence of early colorectal cancer at any one of stages from 0 to 2 can be accurately determined. The colorectal cancer inspection method includes: measuring the amounts of at least lactic acid, pyruvic acid, and glycolic acid among a plurality of kinds of in vivo metabolites contained in a biological sample collected from a test subject, based on data obtained by performing a chromatograph-MS/MS analysis on the biological sample; and determining the presence of colorectal cancer at any one of stages from 0 to 2, based on a measurement value of at least one of the lactic acid, the pyruvic acid, and the glycolic acid.
    Type: Application
    Filed: February 2, 2018
    Publication date: October 18, 2018
    Applicants: SHIMADZU CORPORATION, NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY, NATIONAL CANCER CENTER
    Inventors: Noriyuki OJIMA, Shuichi KAWANA, Yumi UNNO, Takero SAKAI, Kenichi OBAYASHI, Yukihiko KUDO, Masaru YOSHIDA, Shin NISHIUMI, Takashi KOBAYASHI, Takeshi AZUMA, Koji OKAMOTO, Yasuhide YAMADA, Natsuko OKITA, Kazuki SUDO
  • Publication number: 20180284075
    Abstract: At least one stable isotope reagent is added to each biological sample and standard sample to prepare biological samples for analysis and standard sample for analysis. The quality of the biological samples is evaluated using data of one set of biological samples for analysis composed of a plurality of biological samples for analysis. Besides, the quality of a pretreatment and/or analysis of each set of samples for analysis is evaluated using data obtained by analyzing the standard sample for analysis before and after an analysis of one set of samples for analysis. An abnormality in a chromatograph or mass analyzer used for the analysis of one set of samples is evaluated by the data obtained by analyzing a sample for device evaluation before and after the analysis of one set of samples for analysis. Thus, the quality of data obtained by chromatographic mass spectrometry on biological samples is comprehensively evaluated.
    Type: Application
    Filed: February 1, 2018
    Publication date: October 4, 2018
    Applicants: SHIMADZU CORPORATION, NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY
    Inventors: Noriyuki OJIMA, Shuichi KAWANA, Yumi UNNO, Takero SAKAI, Kenichi OBAYASHI, Yukihiko KUDO, Katsuyuki TANEDA, Masaru YOSHIDA, Shin NISHIUMI, Takashi KOBAYASHI, Takeshi AZUMA